Envista Holdings Corporation NVST Clear Aligner Treatment Plans — Remaining performance obligation
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Envista Holdings Corporation in its filing.
Tagged under the XBRL concept us-gaap:RevenueRemainingPerformanceObligation.
The official record: Envista Holdings Corporation’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Envista Holdings Corporation's clear aligner treatment plans — remaining performance obligation.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Envista Holdings Corporation's clear aligner treatment plans — remaining performance obligation?
- Envista Holdings Corporation (NVST) reported clear aligner treatment plans — remaining performance obligation of $130.8M in Q1 2026.
- How has Envista Holdings Corporation's clear aligner treatment plans — remaining performance obligation changed year-over-year?
- Envista Holdings Corporation's clear aligner treatment plans — remaining performance obligation increased by 19.8% year-over-year, from $109.2M to $130.8M.
- What does clear aligner treatment plans — remaining performance obligation mean?
- This metric represents the aggregate transaction price allocated to clear aligner treatment plans that are promised to customers but have not yet been fully satisfied or delivered. It serves as a forward-looking indicator of future revenue recognition for the orthodontic product segment. By tracking this obligation, investors can assess the backlog of contracted dental treatment services and the company's ability to convert existing sales commitments into recognized revenue over time.